ロード中...
Curative-Intent Treatment with Durvalumab in Early-Stage Cancers
The introduction of immunotherapy has fundamentally transformed the treatment landscape in cancer, providing long-term survival benefit for patients with advanced disease across multiple tumor types, including non-small cell lung cancer (NSCLC). In the placebo-controlled phase 3 PACIFIC trial, the P...
保存先:
| 出版年: | Adv Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8190020/ https://ncbi.nlm.nih.gov/pubmed/33881745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01675-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|